substantial variation in such costs across states and within states for identical combinations of medications. We sought to compare the patterns we found in 2006 PDPs-the first year of Medicare Part D-with PDPs newly available for 2007.
Methods: As in our previous work, 1 we compared the estimated annual costs for 4 prototypical patients with combinations of chronic conditions, using the Medicare Part D 2007 drug plan online calculator provided by the Centers for Medicare and Medicaid Services (available at: http://www.medicare.gov/). We also generated estimates of affordability with the most recent state data regarding median income for zero-earner households. When taking cost-of-living adjusted median income into account, the mean affordability for lowest-cost PDPs was 2.3% of annual income for Case 1, 5.5% for Case 2, 5.9% for Case 3, and 7.6% for Case 4. Although the mean lowest-cost PDPs were all more affordable in 2007 than in 2006, affordability across states for each case varied at least twofold (Table 1) .
Within states, the mean difference between the lowest-cost PDP and highest-cost PDP for the same medications (i.e., fiscal risk of plan selection for beneficiaries) was $2,457 for Case 1, $2,769 for Case 2, $4,525 for Case 3, and $1,781 for Case 4.
Conclusion: In 2007, the lowest-cost Medicare PDPs for 4 prototypical patients are less expensive and more affordable than in 2006. Affordability of lowest-cost PDPs continues to vary, twofold or more for beneficiaries living in different states. Moreover, differences of thousands of dollars between the lowest-cost and highest-cost PDPs within a given state, and the changing dominance of specific plans as the lowest-cost options, continue to underscore how critical it is for Medicare beneficiaries to reconsider the choice of their PDP for each plan year. 
